
|Articles|November 23, 2011
EpiCor Receives NDI Approval
While Embria says its ingredient is protected under FDA’s grandfather clause, company president Paul Faganel said that the move provides additional assurance for its customers and manufacturing partners.
Advertisement
EpiCor, the immune-balancing ingredient from Embria Health Sciences (Ankeny, IA), has received New Dietary Ingredient (NDI) notification from the FDA, the company reports.
While Embria says its ingredient is protected under FDA’s grandfather clause, company president Paul Faganel said that the move provides additional assurance for its customers and manufacturing partners.
Advertisement
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
New Report Calls for Combined Sodium-Potassium Strategy in Hypertension Management
2
Collagen Sourcing and Production Methods for Finished Product Manufacturers
3
RFI Ingredients Takes On Minority Investment From Astanor to Fund Global Expansion
4
Solaray Launches UNLIMIT Line Anchored by Creatine, NMN, and Liposomal NAD+
5





